# Randomised Clinical Trial to Evaluate the Efficacy of an Online Cognitive Rehabilitation Programme (COPERIA-COG) for Patients With Persistent COVID-19

> **NCT05629897** · NA · UNKNOWN · sponsor: **Fundacin Biomedica Galicia Sur** · enrollment: 88 (estimated)

## Conditions studied

- COVID-19
- Neuro-Degenerative Disease
- Psychological
- SARS CoV 2 Infection

## Interventions

- **OTHER:** Sessions of cognitive stimulation

## Key facts

- **NCT ID:** NCT05629897
- **Lead sponsor:** Fundacin Biomedica Galicia Sur
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-12-14
- **Primary completion:** 2023-11
- **Final completion:** 2023-11
- **Target enrollment:** 88 (ESTIMATED)
- **Last updated:** 2022-12-02

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05629897

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05629897, "Randomised Clinical Trial to Evaluate the Efficacy of an Online Cognitive Rehabilitation Programme (COPERIA-COG) for Patients With Persistent COVID-19". Retrieved via AI Analytics 2026-06-22 from https://api.ai-analytics.org/clinical/NCT05629897. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*